Literature DB >> 6693398

Glucocorticoid-receptor complexes in rat thymus cells. Rapid kinetic behavior and a cyclic model.

A Munck, N J Holbrook.   

Abstract

We have studied the kinetics, on time scales of minutes and seconds, of formation and interconversion of glucocorticoid-receptor complexes in rat thymus cells under physiological conditions. Nonactivated and activated complexes were measured by a minicolumn technique that permits rapid, multiple simultaneous assays. The rate-limiting step in formation of nuclear complexes was activation, which at 37 degrees C had a half-time of 30-60 s. Activation in cells at 25 degrees C followed first order kinetics. Nuclear binding at 37 degrees C was too fast to measure, and probably has a half-time below 10 s. Earlier findings suggesting that triamcinolone acetonide and dexamethasone give higher steady state ratios of activated to nonactivated complexes than cortisol and corticosterone have been supported by showing that these ratios are concentration-independent, and are unlikely to be due to degradation or dissociation of complexes after cell disruption. A simple cyclic model of receptor kinetics, in which each glucocorticoid is characterized by its dissociation rate constant, accounts quantitatively for these results and many others. The model is based on the assumptions that activation is irreversible, and that energy is required for regenerating functional receptors after each cycle. It yields steady state ratios of activated to nonactivated complexes in agreement with experiment without introducing steroid-specific allosteric influences on activation, and suggests a new mechanism for explaining agonist-antagonist relationships.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6693398

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  Discrimination between NL1- and NL2-mediated nuclear localization of the glucocorticoid receptor.

Authors:  J G Savory; B Hsu; I R Laquian; W Giffin; T Reich; R J Haché; Y A Lefebvre
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

2.  Second generation model for prednisolone pharmacodynamics in the rat.

Authors:  A I Nichols; F D Boudinot; W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1989-04

3.  Estradiol receptor has proteolytic activity that is responsible for its own transformation.

Authors:  G A Puca; C Abbondanza; V Nigro; I Armetta; N Medici; A M Molinari
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

4.  Estrogen receptor beta activation prevents glucocorticoid receptor-dependent effects of the central nucleus of the amygdala on behavior and neuroendocrine function.

Authors:  Michael J Weiser; Chad D Foradori; Robert J Handa
Journal:  Brain Res       Date:  2010-04-08       Impact factor: 3.252

5.  Fourth-generation model for corticosteroid pharmacodynamics: a model for methylprednisolone effects on receptor/gene-mediated glucocorticoid receptor down-regulation and tyrosine aminotransferase induction in rat liver.

Authors:  Y N Sun; D C DuBois; R R Almon; W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1998-06

Review 6.  The road less traveled: new views of steroid receptor action from the path of dose-response curves.

Authors:  S Stoney Simons; Carson C Chow
Journal:  Mol Cell Endocrinol       Date:  2011-06-01       Impact factor: 4.102

7.  PA1 protein, a new competitive decelerator acting at more than one step to impede glucocorticoid receptor-mediated transactivation.

Authors:  Zhenhuan Zhang; Yunguang Sun; Young-Wook Cho; Carson C Chow; S Stoney Simons
Journal:  J Biol Chem       Date:  2012-11-17       Impact factor: 5.157

8.  Third-generation model for corticosteroid pharmacodynamics: roles of glucocorticoid receptor mRNA and tyrosine aminotransferase mRNA in rat liver.

Authors:  Z X Xu; Y N Sun; D C DuBois; R R Almon; W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1995-04

9.  Glucocorticoid and cAMP induction mechanisms are differentially affected by the p85gag-mos oncoprotein.

Authors:  B J Hamilton; D DeFranco
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

10.  Receptor-mediated methylprednisolone pharmacodynamics in rats: steroid-induced receptor down-regulation.

Authors:  D B Haughey; W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1992-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.